SCLX Q4 2024 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q4 2024 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$15M+10.7% YoY

Gross Profit

$10M68.5% margin

Operating Income

-$28M-190.5% margin

Net Income

-$6M-43.4% margin

EPS (Diluted)

$-1.23

QoQ Revenue Growth

+3.2%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$2M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$93M

Total Liabilities

$286M

Stockholders' Equity

-$193M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$13M	+10.7%
Gross Profit	$10M	$8M	+29.1%
Operating Income	-$28M	-$18M	-54.7%
Net Income	-$6M	-$21M	+69.8%